Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
Clinical trial NCT05807542 · COMPLETED
Trial details
- NCT number
- NCT05807542
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.